Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.17, Iss.4, 2003-01, pp. : 285-291
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The management of neurological and psychiatric disorders is a vast and evolving area for researchers, primary care physicians and specialists. To help you keep up to date with the latest advances worldwide on all aspects of drug therapy for neurological and psychiatric disorders, this new section of the journal brings you information selected from the drug therapy reporting service
Related content
Opinion and Evidence in Neurology and Psychiatry
CNS Drugs, Vol. 17, Iss. 6, 2003-01 ,pp. :
Access to resources
Recommend
Opinion and Evidence in Neurology and Psychiatry
By Limited A.I.
CNS Drugs, Vol. 17, Iss. 14, 2003-01 ,pp. :
Opinion and Evidence in Neurology and Psychiatry
By Limited A.I.
CNS Drugs, Vol. 17, Iss. 10, 2003-01 ,pp. :
Opinion and Evidence in Neurology and Psychiatry
CNS Drugs, Vol. 17, Iss. 3, 2003-01 ,pp. :
Opinion and Evidence in Neurology and Psychiatry
CNS Drugs, Vol. 17, Iss. 5, 2003-01 ,pp. :